Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 31
-1
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

    Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

    This survey research study aims to explore the amount of confidence emergency physicians have with treating...

    Human placentophagy: What is the microbial composition of raw and processed placental tissue?

    Placentophagy is gaining in popularity as supporters of this behavior claim it has the ability to improve...

    Backer Badge Funded